Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies
作者： Hitoshi Honda , Yasuo Sakurai , Jong-Hon Kang , Tadahiro Nakamura , Hirotaka Matsuura
DOI: 10.1016/J.AJIC.2013.01.018
关键词:
摘要: The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year in malignancies, at a tertiary care center Japan. was 1.9 per 10,000 catheter-days.
cdc.gov
ajicjournal.org
elsevier.com参考文章(9)
Nancy Kemeny, Ying Huang, Alfred M. Cohen, Weiji Shi, John A. Conti, Murray F. Brennan, Joseph R. Bertino, Alan D.M. Turnbull, Deidre Sullivan, Jennifer Stockman, Leslie H. Blumgart, Yuman Fong, Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer New England Journal of Medicine. ,vol. 341, pp. 2039- 2048 ,(1999) , 10.1056/NEJM199912303412702
Teresa C. Horan, Mary Andrus, Margaret A. Dudeck, CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control. ,vol. 36, pp. 309- 332 ,(2008) , 10.1016/J.AJIC.2008.03.002
Delia Kuizon, Steven M. Gordon, Bart L. Dolmatch, Single-Lumen Subcutaneous Ports Inserted by Interventional Radiologists in Patients Undergoing Chemotherapy Archives of Internal Medicine. ,vol. 161, pp. 406- 410 ,(2001) , 10.1001/ARCHINTE.161.3.406
Alan L BISNO, Edward L KAPLAN, Dennis G MAKI, Daniel M KLUGER, Christopher J CRNICH, None, The Risk of Bloodstream Infection in Adults With Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies Mayo Clinic Proceedings. ,vol. 81, pp. 1159- 1171 ,(2006) , 10.4065/81.9.1159
Bert Hildebrandt, Maciej Pech, Annett Nicolaou, Jan M Langrehr, Jacek Kurcz, Birgit Bartels, Alexandra Miersch, Roland Felix, Peter Neuhaus, Hanno Riess, Bernd Dörken, Jens Ricke, Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach. BMC Cancer. ,vol. 7, pp. 69- 69 ,(2007) , 10.1186/1471-2407-7-69
Archie N. Tse, Nian Wu, Dina Patel, Dana Haviland, Nancy Kemeny, A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies Cancer Chemotherapy and Pharmacology. ,vol. 64, pp. 935- 944 ,(2009) , 10.1007/S00280-009-0945-5
Robert J. Sherertz, David K. Warren, Leonard A. Mermel, Michael Allon, Emilio Bouza, Donald E. Craven, Patricia Flynn, Naomi P. O'Grady, Issam I. Raad, Bart J. A. Rijnders, Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America Clinical Infectious Diseases. ,vol. 49, pp. 1- 45 ,(2009) , 10.1086/599376
Steven R. Alberts, Mark S. Roh, Michelle R. Mahoney, Michael J. O'Connell, David M. Nagorney, Lawrence Wagman, Thomas C. Smyrk, Timothy L. Weiland, Lily Lau Lai, Roderich E. Schwarz, Roy Molina, Todor Dentchev, John S. Bolton, Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66 Journal of Clinical Oncology. ,vol. 28, pp. 853- 858 ,(2010) , 10.1200/JCO.2009.24.6728
B Momin, L. C. Richardson, S. O'Connor, M. Watson, J. W. Ward, Hepatocellular carcinoma - United States, 2001-2006. Morbidity and Mortality Weekly Report. ,vol. 59, pp. 517- 520 ,(2010)